<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637012</url>
  </required_header>
  <id_info>
    <org_study_id>2.0, 2011-12-01</org_study_id>
    <nct_id>NCT01637012</nct_id>
  </id_info>
  <brief_title>Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease</brief_title>
  <acronym>ALEX OCT</acronym>
  <official_title>Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease. Study With Angiography and OCT Follow-up.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balton Sp.zo.o.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KCRI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Balton Sp.zo.o.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of the ALEX stent in a real-world setting of
      percutaneous coronary interventions in patients with coronary heart disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multicenter, non-randomized study designed to enroll up to 60 subjects to
      evaluate the safety and effectiveness of the cobalt-chromium sirolimus eluting coronary stent
      ALEX in a real-world setting of percutaneous coronary interventions in patients with coronary
      heart disease.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of stent strut coverage and parameters of restenosis</measure>
    <time_frame>at 12 months follow-up</time_frame>
    <description>Assessment of stent strut coverage and parameters of restenosis in coronary angiography (QCA - Late Lumen Loss) and in OCT (percent of neointimal volume) 12 months follow-up after the baseline procedure in group of first 20 patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of stent strut coverage and parameters of restenosis</measure>
    <time_frame>at 6 months follow-up</time_frame>
    <description>Assessment of stent strut coverage and parameters of restenosis in coronary angiography (QCA - Late Lumen Loss) and in OCT (percent of neointimal volume) 6 months follow-up after the baseline procedure in group of second 20 patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of stent strut coverage and parameters of restenosis</measure>
    <time_frame>at 3 months follow-up</time_frame>
    <description>Assessment of stent strut coverage and parameters of restenosis in coronary angiography (QCA - Late Lumen Loss) and in OCT (percent of neointimal volume) at 3 months follow-up after the baseline procedure in group of third 20 patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>during index hospitalization</time_frame>
    <description>Procedural success during baseline PCI assessed in coronary angiography (QCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of stent thrombosis</measure>
    <time_frame>at 30 days follow-up</time_frame>
    <description>Occurrence of stent thrombosis at 30 days follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of stent thrombosis</measure>
    <time_frame>at 12 months follow-up</time_frame>
    <description>Occurrence of stent thrombosis at 12 months follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Major Adverse Cardiac Events</measure>
    <time_frame>at 30 days follow-up</time_frame>
    <description>Incidence of Major Adverse Cardiac Events (MACEs) at 30 days follow-up defined as death, myocardial infarction target lesion re-PTCA or target lesion bypass graft</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Major Adverse Cardiac Events</measure>
    <time_frame>at 12 months follow-up</time_frame>
    <description>Incidence of Major Adverse Cardiac Events (MACEs) at 12 months follow-up defined as death, myocardial infarction target lesion re-PTCA or target lesion bypass graft</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Stable Angina</condition>
  <condition>Unstable Angina</condition>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>ALEX stent arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>implantation of ALEX stent during index procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implantation</intervention_name>
    <description>index angioplasty with ALEX stent implatation</description>
    <arm_group_label>ALEX stent arm</arm_group_label>
    <other_name>ALEX Stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical Inclusion Criteria:

          -  &gt; 18 years of age

          -  Patient must provide written informed consent prior to procedure using a form that is
             approved by the local Ethics Committee

          -  clinical diagnosis of Stable Angina, Unstable Angina or Myocardial Infarction without
             ST elevation (NSTEMI) or Myocardial Infarction with ST elevation provided the expiry
             of 72 hours of the onset of symptoms and stable clinical and hemodynamical condition
             the Patient with patent postinfarcion artery (TIMI 3) and indications for PCI and next
             stage of revascularization in the other vessels

          -  earlier effective supply of others lesions in others vessels in case of multivessels
             disease

          -  female of childbearing potential must have a negative pregnancy test within 7 days
             prior to enrolment and utilize reliable birth control for 12 months after enrolment

        Angiographic Inclusion Criteria

          -  target lesion stentosis must be &gt; 70% (visual estimate)

          -  Patient eligible for PCI treatment with the ALEX stent system (vessel diameter in
             range of 2.5 to 4.0 mm and length of lesion that allows to cover a single stent with
             maximum length of 30 mm in visual evaluation)

        Exclusion Criteria:

        Clinical Exclusion Criteria

          -  anticipated inablility of the patient to comply with 12 months of antiplatelet
             treatment (e. g. elective non-cardiac surgery following stenting, drug intolerance
             etc.)

          -  acute or chronic renal failure (serum creatinine &gt; 2 mg%, GFR &lt; 60 ml/min/1.73m2)

          -  left ventricular ejection fraction (LVEF) &lt; 40%

          -  cardiogenic shock

          -  short life expectancy (&lt; 1 year)

          -  any significant medical condition which in the investigator's opinion may interference
             with the Patient's optimal participation in the study

          -  current participation in another drug or device clinical trail in which there no be
             reached the primary endpoint or which clinically interferences with trail's enpoints

        Angiographic Exclusion Criteria

          -  chronic total occlusion

          -  calcified lesion which cannot be successfully dilated

          -  location of lesions in the winding vessels where there is no possibility of OCT
             imaging

          -  target stenosis located in venous or arterial bridge

          -  unprotected left main coronary disease with &gt; 50% stenosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacek Legutko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Szpital Uniwersytecki w Krakowie, ul. Kopernika 17, Krakow 31-501, Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dariusz Dudek, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Szpital Uniwersytecki w Krakowie, ul. Kopernika 17, Krakow 31-501, Poland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carint Scanmed Szpital Sw. Rafala</name>
      <address>
        <city>Krakow</city>
        <state>Bochenka 12</state>
        <zip>30-693</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki w Krakowie, Samodzielna Pracownia Zakladu Hemodynamiki i Angiografii</name>
      <address>
        <city>Krakow</city>
        <state>Kopernika 17</state>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polsko-Amerykanskie Kliniki Serca I Oddzial Kardiologiczno-Angiologiczny</name>
      <address>
        <city>Ustron</city>
        <state>Sanatoryjna 7</state>
        <zip>43-450</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polsko-Amerykanskie Kliniki Serca III Oddzial Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii</name>
      <address>
        <city>Dabrowa Gornicza</city>
        <state>Szpitalna 13</state>
        <zip>43-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centralny Szpital Kliniczny MSWiA w Warszawie Klinika Kardiologii Inwazyjnej</name>
      <address>
        <city>Warszawa</city>
        <state>Woloska 137</state>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://www.balton.pl/</url>
    <description>Sponsor</description>
  </link>
  <link>
    <url>http://www.kcri.org/en/core</url>
    <description>Core Laboratory</description>
  </link>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2012</study_first_submitted>
  <study_first_submitted_qc>July 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2012</study_first_posted>
  <last_update_submitted>March 12, 2014</last_update_submitted>
  <last_update_submitted_qc>March 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ALEX</keyword>
  <keyword>coronary stent</keyword>
  <keyword>cobalt-chromium</keyword>
  <keyword>sirolimus</keyword>
  <keyword>OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

